Search
Tearing up the traditional biotech playbook
LabCentral, a crucial Boston incubator for drug discovery, is slated to grow amid industry slowdown
Harnessing Data and Technology to Strategically Change the Playing Field for Biotech
Did a community organizer seal the deal to bring the ARPA-H to Cambridge?
LabCentral 2022 Impact Report: Companies Raised $6.05 Billion in Funding Including 21% of All Early-Stage Funding Nationwide, Granted 56 Patents and Dosed 4,504 Participants in 37 Clinical Trials
Resident and alumni companies also created 1,284…
LabCentral Ignite Launches IgniteVC to Accelerate Diversity and Inclusion In Life Sciences Venture Capital and Innovator Companies, Sustains Industry Grassroots Effort
New initiative offers range of DEI tools and…
LabCentral Ignite Launches Third Annual Golden Ticket Contest
Eight Golden Tickets offer more opportunity for…
LabCentral and Astellas Launch Inaugural $500,000 "Diamond Ticket" at LabCentral 238
Eight Golden Tickets offer more opportunity for…
LabCentral Joins ARPA-H Investor Catalyst Hub Spoke Network
‐New program, the largest of its kind, provides…